
Ezetimibe More Effective on a Ketogenic Diet
Study proposes a novel insulin-centered mechanism for ketogenic diet-associated hypercholesteremia and highlights a potential new approach to lipid management TOWARD Health is proud to announce
Dr. Kelly Curtis serves as Associate Director of Research at TOWARD Health, where she helps develop and implement research initiatives focused on metabolic health, chronic disease, and innovative models of care. She earned her bachelor’s degree in psychology, magna cum laude, from Colgate University and received her medical degree from the Geisel School of Medicine at Dartmouth in 2023. Before joining TOWARD Health, Dr. Curtis conducted research at the University of Florida’s Norman Fixel Institute for Neurological Diseases in collaboration with Florida’s Alzheimer’s Disease Research Center. She has also worked on clinical trials evaluating investigational therapies designed to lower lipoprotein(a), an important inherited risk factor for cardiovascular disease. Her research interests span metabolic, cardiovascular, and neurological health, with a particular emphasis on translating scientific evidence into meaningful improvements in patient care. Dr. Curtis is passionate about addressing the shortcomings of conventional healthcare, including its limited emphasis on prevention and nutrition, disparities in access to care, slow adoption of evidence-based practices, and reliance on brief, medication-focused visits. At TOWARD Health, she is committed to advancing rigorous, patient-centered research that supports more preventive, accessible, and effective approaches to chronic disease. Outside of work, Dr. Curtis enjoys singing, creating art, participating in church fellowship, and spending time with her family. She is also deeply devoted to her beloved cat, Ben.

Study proposes a novel insulin-centered mechanism for ketogenic diet-associated hypercholesteremia and highlights a potential new approach to lipid management TOWARD Health is proud to announce
New program introduces physician-led, data-driven model to improve chronic disease management, reduce medication burden, and enhance quality of life in assisted living residents TOWARD
New publication highlights historic FDA decision and calls for a shift from fear-based to evidence-based menopause care TOWARD Health is proud to announce that